Sie sind auf Seite 1von 3

14.12.

2006 EN Official Journal of the European Union L 354/5

COMMISSION REGULATION (EC) No 1831/2006


of 13 December 2006
amending Annex I to Council Regulation (EEC) No 2377/90 laying down a Community procedure
for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of
animal origin, as regards Doramectin
(Text with EEA relevance)

THE COMMISSION OF THE EUROPEAN COMMUNITIES, excluding animals from which milk is produced for
human consumption.

Having regard to the Treaty establishing the European (3) Regulation (EEC) No 2377/90 should therefore be
Community, amended accordingly.

(4) An adequate period should be allowed before the appli-


Having regard to Council Regulation (EEC) No 2377/90 of 26 cability of this Regulation in order to enable Member
June 1990 laying down a Community procedure for the estab- States to make any adjustment which may be necessary
lishment of maximum residue limits of veterinary medicinal in the light of this Regulation to the authorisations to
products in foodstuffs of animal origin (1), and in particular place the veterinary medicinal products concerned on the
Article 2 thereof, market which have been granted in accordance with
Directive 2001/82/EC of the European Parliament and
of the Council of 6 November 2001 on the
Community code relating to veterinary medicinal
products (2) to take account of the provisions of this
Having regard to the opinions of the European Medicines Regulation.
Agency formulated by the Committee for Medicinal Products
for Veterinary Use,

(5) The measures provided for in this Regulation are in


accordance with the opinion of the Standing
Committee on Veterinary Medicinal Products,
Whereas:

HAS ADOPTED THIS REGULATION:

(1) All pharmacologically active substances used in the


Community in veterinary medicinal products intended
for food-producing animals should be evaluated in
Article 1
accordance with Regulation (EEC) No 2377/90.
Annex I to Regulation (EEC) No 2377/90 is amended in
accordance with the Annex to this Regulation.

(2) The substance Doramectin is included in Annex I to


Regulation (EEC) No 2377/90 for bovine for muscle, Article 2
fat, liver and kidney excluding bovines producing milk
for human consumption. This substance is also included This Regulation shall enter into force on the third day following
in Annex I to Regulation (EEC) No 2377/90 for porcine, that of its publication in the Official Journal of the European
ovine, deer, including reindeer, for muscle, fat, liver and Union.
kidney excluding ovines producing milk for human
consumption. The entry for Doramectin in that Annex
should be modified and extended to all mammalian food-
producing species for muscle, fat, liver and kidney,
It shall apply from 12 February 2007.
(1) OJ L 224, 18.8.1990, p. 1. Regulation as last amended by
Commission Regulation (EC) No 1805/2006 (OJ L 343, (2) OJ L 311, 28.11.2001, p. 1. Directive as last amended by Directive
8.12.2006, p. 66). 2004/28/EC (OJ L 136, 30.4.2004, p. 58).
L 354/6 EN Official Journal of the European Union 14.12.2006

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 13 December 2006.

For the Commission


Günter VERHEUGEN
Vice-President
ANNEX

The following substance is inserted in Annex I to Regulation (EEC) No 2377/90:


14.12.2006

2. Antiparasitic agents
2.3. Agents acting against endo- and ectoparasites
EN

2.3.1. Avermectins

Pharmacologically active Substance(s) Marker residue Animal species MRLs Target tissues

‘Doramectin Doramectin All mammalian food producing species (1) 40 μg/kg Muscle

150 μg/kg Fat

100 μg/kg Liver

60 μg/kg Kidney

(1) Not for use in animals from which milk is produced for human consumption.’
Official Journal of the European Union
L 354/7